The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Medivation; Bayer; Dendreon; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Exelixis; Genentech/Roche; Innocrin Pharma; Merck; Novartis; Sanofi
Speakers' Bureau - Bayer; Dendreon; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Medivation (Inst); Bayer (Inst); Celldex (Inst); Dendreon (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst)
Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance).
 
Daniel J. George
No Relationships to Disclose
 
Susan Halabi
Consulting or Advisory Role - Dendreon; Eisai; Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Dendreon
 
Mark D. Starr
No Relationships to Disclose
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
John C. Brady
No Relationships to Disclose
 
Ian Barak
No Relationships to Disclose
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Endocyte
Research Funding - Bayer (Inst); Endocyte (Inst); Progenics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Eric Jay Small
Research Funding - Janssen (Inst)
 
Won Kim
Consulting or Advisory Role - Bayer; Dendreon; Genentech/Roche
Research Funding - Novartis
 
Mary-Ellen Taplin
Honoraria - Bayer; Dendreon; Janssen-Ortho; Medivation; Tokai Pharmaceuticals
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Clovis Oncology; Dava Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen-Ortho; Medivation; Parexel; Research to Practice; Sanofi; Tokai Pharmaceuticals; UpToDate
Research Funding - Bayer; Genentech; Janssen-Ortho; Medivation; Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Oncology; Medivation; Tokai Pharmaceuticals
 
Andrew B. Nixon
Consulting or Advisory Role - Cerulean Pharma; Novartis; Pfizer
Research Funding - Acceleron Pharma; Amgen; Genentech/Roche; Incyte; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent pending (Inst); Patent Pending (Inst)